Hims & Hers Health Inc. (HIMS)

AI Score

Unlock

26.89

-2.57 (-8.72%)

At close: Apr 16, 2025, 3:59 PM

26.93

0.15%

After-hours: Apr 16, 2025, 04:06 PM EDT

Dividends

No dividend history available for Hims & Hers Health Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield
The Procter & Gamble Company	2.42%
Colgate-Palmolive Company	2.14%
Kenvue Inc.	3.89%
The Estée Lauder Companies Inc.	2.81%
Coty Inc.	4.38%
Inter Parfums, Inc.	2.4%
Newell Brands Inc.	4.36%

Dividend Rankings

HIMS News

Just now · Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - zacks.com
5 days ago · Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know - zacks.com
6 days ago · Hims' Weight Loss Expansion: Real Growth or Just Hype? - marketbeat.com
1 week ago · Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - zacks.com
2 weeks ago · Why Hims & Hers Health Stock Couldn't Beat the Market Today - fool.com
2 weeks ago · 3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes - zacks.com
2 weeks ago · Hims & Hers shares rise as company adds Eli Lilly's Zepbound - youtube.com
2 weeks ago · Why Hims & Hers Health Stock Soared Tuesday - fool.com
2 weeks ago · Hims & Hers shares rise as company adds new weight-loss medications to platform - cnbc.com
2 weeks ago · Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound - investors.com